M1A-regulated DIAPH3 Promotes the Invasiveness of Colorectal Cancer Via Stabilization of KRT19

Overview

Journal Clin Exp Metastasis

Date 2025 Jan 22

PMID 39843730

Authors

Shuyi Mi

Jie Hu

Wenwen Chen

Jingyu Chen

Zhipeng Xu

Meng Xue

Affiliations

Soon will be listed here.

Abstract

Background: In recent years, the emphasis has shifted to understanding the role of N1-methyladenosine (m1A) in tumor progression as little is known about its regulatory effect on mRNA and its role in the metastasis of colorectal cancer (CRC).

Methods: We performed methylated RNA immunoprecipitation sequencing of tumor tissues and tumor-adjacent normal tissues from three patients with CRC to determine the m1A profile of mRNA in CRC. The expression of diaphanous-related formin 3 (DIAPH3) and its correlation with clinicopathological characteristics of CRC were evaluated using immunohistochemistry and online datasets. The role of DIAPH3 in the migration and invasion of CRC cells was evaluated using wound healing assay, Transwell assay and xenograft metastatic model. The downstream targets of DIAPH3 were screened using mass spectrometry. By co-transfecting DIAPH3 siRNA and a keratin 19 (KRT19) ectopic plasmid into CRC cells, the role of DIAPH3-KRT19 signaling axis was confirmed.

Results: The mRNA level of DIAPH3 and its m1A modifications increased simultaneously in the CRC tissues. In addition, high DIAPH3 expression in CRC tissues is significantly associated with metastasis and progression to an advanced stage. After the knockdown of DIAPH3, the migration and invasion capabilities of CRC cells suffered a notable decline, which could be rescued by overexpressing KRT19. In addition, the proteasome inhibitor MG132 could block the degradation of KRT19 induced by DIAPH3 silencing.

Conclusions: Our study reveals that DIAPH3 mRNA was modified in CRC cells by m1A methylation. Silencing DIAPH3 suppresses the migration and invasion of CRC cells, potentially through the proteasome-dependent degradation of downstream KRT19.

References

Shen L, Shao N, Liu X, Maze I, Feng J, Nestler E . diffReps: detecting differential chromatin modification sites from ChIP-seq data with biological replicates. PLoS One. 2013; 8(6):e65598. PMC: 3677880. DOI: 10.1371/journal.pone.0065598. View

Wu X, Zheng Y, Liu M, Li Y, Ma S, Tang W . BNIP3L/NIX degradation leads to mitophagy deficiency in ischemic brains. Autophagy. 2020; 17(8):1934-1946. PMC: 8386707. DOI: 10.1080/15548627.2020.1802089. View

Boccaletto P, Stefaniak F, Ray A, Cappannini A, Mukherjee S, Purta E . MODOMICS: a database of RNA modification pathways. 2021 update. Nucleic Acids Res. 2021; 50(D1):D231-D235. PMC: 8728126. DOI: 10.1093/nar/gkab1083. View

Trapnell C, Williams B, Pertea G, Mortazavi A, Kwan G, van Baren M . Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol. 2010; 28(5):511-5. PMC: 3146043. DOI: 10.1038/nbt.1621. View

Wu Y, Chen Z, Xie G, Zhang H, Wang Z, Zhou J . RNA mA methylation regulates glycolysis of cancer cells through modulating ATP5D. Proc Natl Acad Sci U S A. 2022; 119(28):e2119038119. PMC: 9282374. DOI: 10.1073/pnas.2119038119. View

Zhao B, Roundtree I, He C . Post-transcriptional gene regulation by mRNA modifications. Nat Rev Mol Cell Biol. 2016; 18(1):31-42. PMC: 5167638. DOI: 10.1038/nrm.2016.132. View

Zhao Y, Zhao Q, Jabbarzadeh Kaboli P, Shen J, Li M, Wu X . m1A Regulated Genes Modulate PI3K/AKT/mTOR and ErbB Pathways in Gastrointestinal Cancer. Transl Oncol. 2019; 12(10):1323-1333. PMC: 6661385. DOI: 10.1016/j.tranon.2019.06.007. View

Porcellini E, Laprovitera N, Riefolo M, Ravaioli M, Garajova I, Ferracin M . Epigenetic and epitranscriptomic changes in colorectal cancer: Diagnostic, prognostic, and treatment implications. Cancer Lett. 2018; 419:84-95. DOI: 10.1016/j.canlet.2018.01.049. View

He L, Li H, Wu A, Peng Y, Shu G, Yin G . Functions of N6-methyladenosine and its role in cancer. Mol Cancer. 2019; 18(1):176. PMC: 6892141. DOI: 10.1186/s12943-019-1109-9. View

10.

McShane E, Selbach M . Physiological Functions of Intracellular Protein Degradation. Annu Rev Cell Dev Biol. 2022; 38:241-262. DOI: 10.1146/annurev-cellbio-120420-091943. View

11.

Zhang L, Liu C, Ma H, Dai Q, Sun H, Luo G . Transcriptome-wide Mapping of Internal N-Methylguanosine Methylome in Mammalian mRNA. Mol Cell. 2019; 74(6):1304-1316.e8. PMC: 6588483. DOI: 10.1016/j.molcel.2019.03.036. View

12.

Wang Y, Wang J, Li X, Xiong X, Wang J, Zhou Z . N-methyladenosine methylation in tRNA drives liver tumourigenesis by regulating cholesterol metabolism. Nat Commun. 2021; 12(1):6314. PMC: 8563902. DOI: 10.1038/s41467-021-26718-6. View

13.

Smith J, Deane N, Wu F, Merchant N, Zhang B, Jiang A . Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology. 2009; 138(3):958-68. PMC: 3388775. DOI: 10.1053/j.gastro.2009.11.005. View

14.

Lizarraga F, Poincloux R, Romao M, Montagnac G, Le Dez G, Bonne I . Diaphanous-related formins are required for invadopodia formation and invasion of breast tumor cells. Cancer Res. 2009; 69(7):2792-800. DOI: 10.1158/0008-5472.CAN-08-3709. View

15.

Xue M, Mi S, Zhang Z, Wang H, Chen W, Wei W . MFAP2, upregulated by m1A methylation, promotes colorectal cancer invasiveness via CLK3. Cancer Med. 2022; 12(7):8403-8414. PMC: 10134263. DOI: 10.1002/cam4.5561. View

16.

Saha S, Yin Y, Chae H, Cho S . Opposing Regulation of Cancer Properties via KRT19-Mediated Differential Modulation of Wnt/β-Catenin/Notch Signaling in Breast and Colon Cancers. Cancers (Basel). 2019; 11(1). PMC: 6357186. DOI: 10.3390/cancers11010099. View

17.

Dong L, Li Z, Xue L, Li G, Zhang C, Cai Z . DIAPH3 promoted the growth, migration and metastasis of hepatocellular carcinoma cells by activating beta-catenin/TCF signaling. Mol Cell Biochem. 2017; 438(1-2):183-190. DOI: 10.1007/s11010-017-3125-7. View

18.

Rong Y, Gao J, Kuang T, Chen J, Li J, Huang Y . DIAPH3 promotes pancreatic cancer progression by activating selenoprotein TrxR1-mediated antioxidant effects. J Cell Mol Med. 2020; 25(4):2163-2175. PMC: 7882936. DOI: 10.1111/jcmm.16196. View

19.

Kim D, Paggi J, Park C, Bennett C, Salzberg S . Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat Biotechnol. 2019; 37(8):907-915. PMC: 7605509. DOI: 10.1038/s41587-019-0201-4. View

20.

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View